Description

Listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued to non-promoters on preferential basis pursuant to conversion of warrants, effective December 30, 2025.

Summary

BSE has announced the listing of 7,67,407 new equity shares of Vivo Bio Tech Ltd. (Scrip Code: 511509) effective from December 30, 2025. These shares were issued at Rs. 45/- per share (face value Rs. 10/- plus premium of Rs. 35/-) to non-promoters on a preferential basis pursuant to conversion of warrants. The shares are subject to lock-in until June 30, 2026.

Key Points

  • 7,67,407 equity shares of Rs. 10/- each issued at premium of Rs. 35/-
  • Issued to non-promoters on preferential basis through warrant conversion
  • Issue price: Rs. 45/- per share
  • Date of allotment: September 24, 2025
  • New shares rank pari-passu with existing equity shares
  • Distinctive numbers: 21333222 to 22100628
  • ISIN: INE380K01017
  • Complete lock-in until June 30, 2026 for all 7,67,407 shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification following SEBI guidelines for preferential allotment and warrant conversion.

Compliance Requirements

  • Trading members are informed that these securities are listed and permitted to trade from December 30, 2025
  • Lock-in restrictions must be observed until June 30, 2026
  • All 7,67,407 shares remain locked-in and cannot be transferred during the lock-in period

Important Dates

  • Allotment Date: September 24, 2025
  • Listing and Trading Commencement: December 30, 2025 (Tuesday)
  • Lock-in Expiry: June 30, 2026

Impact Assessment

This is a company-specific listing event with minimal market-wide impact. The preferential allotment represents capital raising activity for Vivo Bio Tech Ltd. The lock-in period ensures price stability by preventing immediate selling pressure from allottees. Trading members should note the lock-in restrictions when processing transactions in these specific distinctive number ranges.

Impact Justification

Routine listing notification for preferential allotment affecting a specific company with limited market-wide impact. Standard lock-in provisions apply.